NCT05842044PHASE2Recruiting
NSAID Use After Robotic Partial Nephrectomy
University of Miami
Start Date
9/15/2023
Completion Date
9/30/2026
Summary
The purpose of this study is to see how effective non-steroidal anti-inflammatory drugs (NSAIDs) are at controlling pain without side effects in participants after robotic-assisted partial nephrectomy.
Eligibility Criteria
Age Range: 18 years to 99 years
Inclusion Criteria:
* Patients undergoing uncomplicated robotic assisted laparoscopic partial nephrectomy for renal mass at the University of Miami Hospital and Network Sites (Deerfield Beach, Plantation, Lennar (Coral Gables), and Kendal).
* Age 18-99.
* Ability to understand and the willingness to sign a written informed consent document.
Exclusion Criteria:
* Allergy to NSAIDs
* Myocardial infarction or unstable angina within 12 months.
* Any history of coronary artery bypass graft surgery.
* History or active peptic ulcer disease, gastrointestinal (GI) bleeding, GI perforation. History of bleeding disorder. Glomerular filtration rate (GFR) \< 60 mL/min/1.73m2 (Modification of Diet in Renal Disease (MDRD) equation).
* Taking any anti-platelet or anti-coagulation medications concurrently (e.g. warfarin, aspirin, clopidogrel, rivaroxaban etc.)
* Chronic opioid use (use within 12 weeks) or history of opioid use disorder.
* Solitary kidney.
* Pregnancy.
* Inability to give informed consent or unable to meet requirement of the study for any reason.
Interventions
DRUG
Ketorolac
DRUG
Acetaminophen
DRUG
Oxycodone
DRUG
Hydromorphone
DRUG
Ibuprofen
Conditions
Kidney CancerRenal CancerRenal Neoplasm
Locations
University of Miami
Miami, Florida 33136
United States